Trial · NCT02993159
Results by group48
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 48
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Ki-67 Labeling Index | Arm I (4-OHT Topical Gel, Placebo) | -1.0 | 95% Confidence Interval -2.4 to 0.52 | percent positive cells | |
| Change in Ki-67 Labeling Index | Arm II (Placebo, Oral Tamoxifen) | -4.8 | 95% Confidence Interval -6.6 to -3.1 | percent positive cells | |
| Change in Oncotype DCIS-Score | Arm I (4-OHT Topical Gel, Placebo) | -1.8 | 95% Confidence Interval -5.8 to 2.3 | score on a scale | |
| Change in Oncotype DCIS-Score | Arm II (Placebo, Oral Tamoxifen) | -16 | 95% Confidence Interval -22 to -9.4 | score on a scale | |
| Post-therapy Breast Tissue Levels of Tamoxifen and Its Metabolites | Arm I (4-OHT Topical Gel, Placebo) | 4-OHT, Superficial tissue sample | 4.2 | Inter-Quartile Range 1.5 to 17.8 | ng/g |
| Post-therapy Breast Tissue Levels of Tamoxifen and Its Metabolites | Arm II (Placebo, Oral Tamoxifen) | 4-OHT, Superficial tissue sample | 6.0 | Inter-Quartile Range 3.9 to 8.5 | ng/g |
| Post-therapy Breast Tissue Levels of Tamoxifen and Its Metabolites | Arm I (4-OHT Topical Gel, Placebo) | 4-OHT, Deep tissue sample | 3.8 | Inter-Quartile Range 1.3 to 7.9 | ng/g |
| Post-therapy Breast Tissue Levels of Tamoxifen and Its Metabolites | Arm II (Placebo, Oral Tamoxifen) | 4-OHT, Deep tissue sample | 5.7 | Inter-Quartile Range 4.0 to 7.9 | ng/g |
| Post-therapy Breast Tissue Levels of Tamoxifen and Its Metabolites | Arm I (4-OHT Topical Gel, Placebo) | Endoxifen, Superficial tissue sample | 0.2 | Inter-Quartile Range 0.2 to 0.3 | ng/g |
| Post-therapy Breast Tissue Levels of Tamoxifen and Its Metabolites | Arm II (Placebo, Oral Tamoxifen) | Endoxifen, Superficial tissue sample | 16 | Inter-Quartile Range 9.5 to 20.7 | ng/g |
| Post-therapy Breast Tissue Levels of Tamoxifen and Its Metabolites | Arm I (4-OHT Topical Gel, Placebo) | 4-OHT, Deep tissue sample | 0.3 | Inter-Quartile Range 0.0 to 0.3 | ng/g |
| Post-therapy Breast Tissue Levels of Tamoxifen and Its Metabolites | Arm II (Placebo, Oral Tamoxifen) | 4-OHT, Deep tissue sample | 13 | Inter-Quartile Range 8.9 to 20.6 | ng/g |
| Post-therapy Plasma Levels of Tamoxifen and Its Metabolites | Arm I (4-OHT Topical Gel, Placebo) | 4-OHT, Plasma | 0.2 | Inter-Quartile Range 0.1 to 0.4 | ng/ml |
| Post-therapy Plasma Levels of Tamoxifen and Its Metabolites | Arm II (Placebo, Oral Tamoxifen) | 4-OHT, Plasma | 2.0 | Inter-Quartile Range 1.4 to 2.7 | ng/ml |
| Post-therapy Plasma Levels of Tamoxifen and Its Metabolites | Arm I (4-OHT Topical Gel, Placebo) | Endoxifen, Plasma | 0.0 | Inter-Quartile Range 0.0 to 0.0 | ng/ml |
| Post-therapy Plasma Levels of Tamoxifen and Its Metabolites | Arm II (Placebo, Oral Tamoxifen) | Endoxifen, Plasma | 10.5 | Inter-Quartile Range 6.4 to 13.8 | ng/ml |
| Ki-67 Labelling Index in the Terminal Duct Lobular Units (TDLUs) | Arm I (4-OHT Topical Gel, Placebo) | -0.11 | 95% Confidence Interval -1.20 to 0.98 | percent positive | |
| Ki-67 Labelling Index in the Terminal Duct Lobular Units (TDLUs) | Arm II (Placebo, Oral Tamoxifen) | 0.16 | 95% Confidence Interval -0.67 to 0.99 | percent positive | |
| Change in Plasma Proteins Involved in Coagulation | Arm I (4-OHT Topical Gel, Placebo) | Factor VIII | -0.50 | 95% Confidence Interval -12 to 11 | percent |
| Change in Plasma Proteins Involved in Coagulation | Arm II (Placebo, Oral Tamoxifen) | Factor VIII | -8.8 | 95% Confidence Interval -19 to 1.5 | percent |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02993159/results